Navigating the Changing Landscape in HER2-Positive Breast Cancer
March 9th 2020
The paradigm for treating patients with HER2-positive breast cancer is changing throughout the spectrum of the disease as a result of recent clinical trial findings regarding novel and established treatment regimens, according to Sara A. Hurvitz, MD